Subscriptions are live: We're on the subscription model now, early-access price $24.99/month, with day, week, and longer plans too. New accounts start with 5 free premium days. Prefer to donate? Donations grant premium time and are logged on your profile page.

Plans & pricing
Donate for premium time
Logo
Sign In

$GRI

GRI Bio, Inc. Common Stock

XNAS

$2.18+28.24%+$0.4800Prev $1.70LIVE Full chart Live alerts
No recent price bars, the chart lights up when GRI starts printing.

Why is GRI up today? It is at $2.18 (+28.24%), and our scanner flagged it 26 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment GRI spikes, and full due diligence on GRI — key stats, earnings, dilution and insider activity. Free.

Free alerts

Get free $GRI alerts the moment volume spikes

Our scanner flagged $GRI 26 times in the last 30 days. Create a free account to track $GRI, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.

Real-time RVOL & momentum alerts Personal watchlist & price alerts
Sign up free with email

No card · 5 premium days · join 800+ traders

Key Stats

Price & performance
Price
$2.18
Change today
+28.24%
Previous close
$1.70
52-week range
$1.36 – $80.36
Valuation & dividend
Market cap
$3M
Ownership & volume
Shares outstanding
1.8M
SEC · as of 2026-05-12 · 91d ↗
Institutional own.
1.71%
Total held
1.7%
Tradeable float
1.7M
98% of shares · after 2% institutions
Short interest
126K
▲ +10% vs prior · as of 2026-07-15
Short % of float
7.2%
Days to cover
2.8d
Avg daily volume
144K
Next earnings
Aug 13 · in 2d
Classification
Exchange
XNAS
Relative volumevs this time of day
5mthin
460x
15mthin
631x
1hthin
19x
1D
76x

Get free GRI + market alerts in your inbox

The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.

No spam. Unsubscribe anytime. Not investment advice.

Why is $GRI up today?

19 alerts today29.0x RVOL

GRI is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 19 unusual-volume and momentum alerts on GRI today, peaking at 29.0x its normal volume. A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.

Likely catalystGRI Bio Secures FDA Orphan Drug Designation for GRI-0621 (Tazarotene) in Idiopathic Pulmonary Fibrosis, from the latest SEC filing. Read it →
Why is $GRI moving? →▶ Replay the moveAuto-generated from live scanner data. Not investment advice.
Trading profile📅 Earnings in 2d⚡ Ultra-low float · 1.7M shNot shortableNo SSRBorrow via Alpaca · SSR from Reg SHO 201
Wall Street consensusStrong Buy2 analysts
Avg target $21.00(+863% upside)
Range $10 – $32
2 buy0 hold0 sell

Analyst data via Nasdaq. Not investment advice.

Dilution watch

Active shelf

At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing). If $GRI runs, these filings show who may be positioned to sell new or newly-registered shares into the move.

Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.

$GRI Sentiment

Bullish
Bearish100Bullish
📰 News: 3 bull · 0 bearToday: +28.2%👥 Community: 0 bull · 0 bear

Blend of news sentiment, today’s move, and community votes. Not investment advice.

$GRI Activity

News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.

Alert· 21m ago +16.8% vs EMA
GRI 200EMA (5m) Trending · 75 bars · L3 · +16.79% above EMA · slope +3.33%
at $2.20
Alert· 21m ago +4.1% vs EMA
GRI 50EMA (5m) Trending · 67 bars · L3 · +4.05% above EMA · slope +2.58%
at $2.20
Alert· 1h ago +2.3% vs EMA
GRI 200EMA (1m) Trending · 64 bars · L3 · +2.29% above EMA · slope +0.94%
at $2.12
Alert· 1h ago +2.3% vs EMA
GRI 200EMA (1m) Trending · 64 bars · L3 · +2.29% above EMA · slope +0.94%
at $2.12
Alert· 1h ago +2.3% vs EMA
GRI 200EMA (1m) Trending · 64 bars · L3 · +2.29% above EMA · slope +0.94%
at $2.12
Alert· 2h ago
The Watcher SOLD $GRI at $2.1200 __THOTH_JSON__{"side":"sell","strategyLabel":"The Watcher · day","reason":"time_box","shares":11,"instance":"Rider"}
at $2.12
Alert· 3h ago
The Watcher SOLD $GRI at $2.1800 __THOTH_JSON__{"side":"sell","strategyLabel":"The Watcher · day","reason":"Scale out into strength","shares":17,"instance":"Rider","setup":"coil-under9"}
at $2.18
Alert· 3h ago
The Watcher BOUGHT $GRI at $2.1300 __THOTH_JSON__{"side":"buy","strategyLabel":"The Watcher · day","reason":"day entry · coil-under9","shares":27,"instance":"Rider","setup":"coil-under9"}
at $2.13
Alert· 3h ago 4.5× RVOL
GRI hit 4.494x RVOL at 2:17 PM ET
at $2.20
Alert· 4h ago -0.7% vs EMA
$GRI near 200 EMA: -0.74% from 200 EMA at 1:34 PM ET
at $2.00
Alert· 4h ago -3.00%
$GRI moved -3.00% in 1 min (Level 1) at 1:34 PM ET
at $2.01
Alert· 4h ago 20.7× RVOL
GRI hit 20.706x RVOL at 1:34 PM ET
at $2.00
Alert· 4h ago
The Watcher SOLD $GRI at $2.0900 __THOTH_JSON__{"side":"sell","strategyLabel":"The Watcher · day","reason":"stop_hit","shares":56,"instance":"Rider"}
at $2.09
Alert· 4h ago
The Watcher BOUGHT $GRI at $2.1500 __THOTH_JSON__{"side":"buy","strategyLabel":"The Watcher · day","reason":"day entry · coil-under9","shares":56,"instance":"Rider","setup":"coil-under9"}
at $2.15
Alert· 4h ago
The Watcher SOLD $GRI at $2.1800 __THOTH_JSON__{"side":"sell","strategyLabel":"The Watcher · day","reason":"level_fail","shares":305,"instance":"Rider"}
at $2.18
Alert· 4h ago
The Watcher BOUGHT $GRI at $2.2200 __THOTH_JSON__{"side":"buy","strategyLabel":"The Watcher · day","reason":"day entry · burst-hod","shares":305,"instance":"Rider","setup":"burst-hod"}
at $2.22
Alert· 4h ago +7.87%
$GRI moved +7.87% in 1 min (Level 1) at 1:02 PM ET
at $2.25
Alert· 4h ago 26.5× RVOL
GRI hit 26.474x RVOL at 1:02 PM ET
at $2.21
Alert· 5h ago
The Watcher SOLD $GRI at $2.0600 __THOTH_JSON__{"side":"sell","strategyLabel":"The Watcher · day","reason":"time_box","shares":35,"instance":"Rider"}
at $2.06
Alert· 5h ago
The Watcher BOUGHT $GRI at $2.0500 __THOTH_JSON__{"side":"buy","strategyLabel":"The Watcher · day","reason":"day entry · coil-under9","shares":35,"instance":"Rider","setup":"coil-under9"}
at $2.05
Alert· 5h ago -7.89%
$GRI moved -7.89% in 1 min (Level 1) at 11:51 AM ET
at $2.05
Alert· 5h ago 29.0× RVOL
GRI hit 28.990x RVOL at 11:51 AM ET
at $1.97
Alert· 6h ago
The Watcher SOLD $GRI at $1.9800 __THOTH_JSON__{"side":"sell","strategyLabel":"The Watcher · day","reason":"trend_hold_trail","shares":3,"instance":"Rider"}
at $1.98
Alert· 6h ago
The Watcher BOUGHT $GRI at $1.9000 __THOTH_JSON__{"side":"buy","strategyLabel":"The Watcher · day","reason":"day entry · topplay-first(5m)","shares":8,"instance":"Rider","setup":"topplay-first(5m)"}
at $1.90
Alert· 6h ago
The Watcher SOLD $GRI at $1.9550 __THOTH_JSON__{"side":"sell","strategyLabel":"The Watcher · scalp","reason":"stop_hit","shares":23,"instance":"Rider","setup":"topplay-first(1m)"}
at $1.96
News· SEC EDGAR· 54d ago
GRI Bio, Inc.: GRI Bio Secures FDA Orphan Drug Designation for GRI-0621 (Tazarotene) in Idiopathic Pulmonary Fibrosis
News· SEC EDGAR· 89d ago
GRI Bio, Inc. filed an 8-K: Results of Operations, Other Material Event
News· SEC EDGAR· 90d ago
GRI Bio, Inc. filed a Quarterly report (10-Q)
News· SEC EDGAR· 188d ago
GRI Bio, Inc. filed an 8-K: Results of Operations
News· GlobeNewswire Inc.· 376d ago Bullish
GRI Bio CEO, Marc Hertz, Participates in Virtual Investor “What This Means” Segment
News· GlobeNewswire Inc.· 575d ago Neutral
Windtree Announces the Addition of Leanne Kelly to Its Board of Directors
News· GlobeNewswire Inc.· 596d ago Bullish
GRI Bio Announces European Patent Office Issued a Decision to Grant Notice for Patent Covering GRI-0803 and Its Library of 500+ Proprietary Compounds
News· GlobeNewswire Inc.· 659d ago Bullish
GRI Bio Announces Exercise of Warrants

Also moving today

The tickers our scanner is lighting up most over the last 48 hours.

$ABCL$MTEN$ACHR$HTZ$AUUD$STIM$TENX$SION$QMCO$SCKT$RKLX$JWEL

GRI stock FAQ

Why is $GRI up today?

GRI is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 19 unusual-volume and momentum alerts on GRI today, peaking at 29.0x its normal volume. A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.

What is the GRI stock price today?

GRI last traded at $2.18, up 28.24% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).

When does GRI report earnings?

GRI Bio, Inc. Common Stock (GRI) is next expected to report earnings on Thursday, August 13, 2026, about 2 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.

Where can I see live GRI alerts?

The GRI Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged GRI 26 times in the last 30 days.

What exchange is GRI on?

GRI (GRI Bio, Inc. Common Stock) trades on XNAS, with a market cap of about $3M.

Is GRI good for day trading?

That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge GRI for yourself. This is not investment advice.

Live data from TheDesperateTrader scanner. Not investment advice.